Combination of Dipeptidyl Peptidase-IV Inhibitor, Vildagliptin and Angiotensin-II Receptor Blocker, Varsartan Ameliorates Both Insulin Insufficiency and Insulin Resistance in Mouse Models of Type 2 Diabetes

被引：0
|
作者：
Miyagawa, Katsutoshi
Kondo, Tatsuya
Matsuyama, Rina
Goto, Rieko
Kawashima, Junji
Motoshima, Hiroyuki
Araki, Eiichi
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1879-P
引用
收藏
页码：A482 / A482
页数：1
相关论文
共 26 条
  • [1] Vildagliptin - A dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes
    Schlesselman, Lauren S.
    FORMULARY, 2006, 41 (10) : 494 - +
  • [2] Combination treatment of dipeptidyl peptidase IV inhibitor and angiotensin-II type 1 receptor blocker attenuates progression of nonalcoholic steatohepatitis in rats
    Okura, Yasushi
    Namisaki, Tadashi
    Kaji, Kosuke
    Noguchi, Ryuichi
    Takeda, Kosuke
    Moriya, Kei
    Kitade, Mitsuteru
    Nishimura, Norihisa
    Seki, Kenichiro
    Sato, Shinya
    Takaya, Hiroaki
    Kawaratani, Hideto
    Sawada, Yasuhiko
    Shimozato, Naotaka
    Nakanishi, Keisuke
    Yoshiji, Hitoshi
    HEPATOLOGY, 2016, 64 : 798A - 798A
  • [3] IMPACT OF THE COMBINATION OF DIPEPTIDYL PEPTIDASE IV INHIBITOR AND ANGIOTENSIN-II TYPE 1 RECEPTOR BLOCKER ON HEPATOCARCINOGENESIS IN A RAT MODEL OF NONALCOHOLIC STEATOHEPATITIS
    Okura, Y.
    Namisaki, T.
    Noguchi, R.
    Takeda, K.
    Moriya, K.
    Kitade, M.
    Nishimura, N.
    Sato, S.
    Sawada, Y.
    Kawaratani, H.
    Seki, K.
    Kaji, K.
    Yoshiji, H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S582 - S582
  • [4] Angiotensin II type 1 receptor blocker, valsartan, ameliorates insulin resistance
    Shiuchi, T
    Cui, TX
    Wu, L
    Matsubara, Y
    Li, JM
    Ming, LJ
    Iwai, M
    Horiuchi, M
    JOURNAL OF HYPERTENSION, 2002, 20 : S60 - S61
  • [5] Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed β-cell function in patients with type 2 diabetes
    Mari, A
    Sallas, WM
    He, YL
    Watson, C
    Ligueros-Saylan, M
    Dunning, BE
    Deacon, CF
    Holst, JJ
    Foley, JE
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (08): : 4888 - 4894
  • [6] Improved meal-related β-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year
    Ahrén, B
    Pacini, G
    Foley, JE
    Schweizer, A
    DIABETES CARE, 2005, 28 (08) : 1936 - 1940
  • [7] Angiotensin II type 1 receptor blocker, candesartan ameliorates cognitive impairment in type-2 diabetes mice with improvement of insulin resistance
    Tsukuda, Kana
    Mogi, Masaki
    Li, Jian-Mei
    Iwanami, Jun
    Min, Li-Juan
    Chen, Rui
    Iwai, Masaru
    Horiuchi, Masatsugu
    JOURNAL OF HYPERTENSION, 2006, 24 : 83 - 83
  • [8] Candesartan, an angiotensin-II receptor blocker, ameliorates insulin resistance and hepatosteatosis by reducing intracellular calcium overload and lipid accumulation
    Lee, Jin Wook
    Gu, Hyun-Oh
    Jung, Yunshin
    Jung, YunJae
    Seo, Seung-Yong
    Hong, Jeong-Hee
    Hong, In-Sun
    Lee, Dae Ho
    Kim, Ok-Hee
    Oh, Byung-Chul
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2023, 55 (05): : 910 - 925
  • [9] Candesartan, an angiotensin-II receptor blocker, ameliorates insulin resistance and hepatosteatosis by reducing intracellular calcium overload and lipid accumulation
    Jin Wook Lee
    Hyun-Oh Gu
    Yunshin Jung
    YunJae Jung
    Seung-Yong Seo
    Jeong-Hee Hong
    In-Sun Hong
    Dae Ho Lee
    Ok-Hee Kim
    Byung-Chul Oh
    Experimental & Molecular Medicine, 2023, 55 : 910 - 925
  • [10] Direct Angiotensin II Type 2 Receptor Stimulation Ameliorates Insulin Resistance in Type 2 Diabetes Mice with PPARγ Activation
    Ohshima, Kousei
    Mogi, Masaki
    Jing, Fei
    Iwanami, Jun
    Tsukuda, Kana
    Min, Li-Juan
    Ogimoto, Akiyoshi
    Dahlof, Bjorn
    Steckelings, Ulrike M.
    Unger, Tomas
    Higaki, Jitsuo
    Horiuchi, Masatsugu
    PLOS ONE, 2012, 7 (11):
123